These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 6878375)

  • 1. Clinical experience with Fluosol-DA.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
    Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell substitutes: hemoglobin solution or fluorocarbon?
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Rice CL; Moss GS
    J Trauma; 1982 Sep; 22(9):736-40. PubMed ID: 7120525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Red Cross lecture. Current concepts of oxygen-transporting blood substitutes.
    Bolin RB
    Can J Surg; 1982 Jul; 25(4):422-4. PubMed ID: 7046893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R; Peerless SJ; Hunter IG
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
    Swann KW; Ropper AH; Zervas NT
    Prog Clin Biol Res; 1983; 122():399-404. PubMed ID: 6348787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with Fluosol-DA (20%) in the United States.
    Tremper KK; Levine EM; Waxman K
    Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T; Yokoyama K; Naito R
    Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
    No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T; Ohyanagi H
    Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients.
    Stefaniszyn HJ; Wynands JE; Salerno TA
    J Cardiovasc Surg (Torino); 1985; 26(4):337-42. PubMed ID: 4019576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experience of hemodilution with fluosol-DA (author's transl)].
    Fukushima K; Nakamura M; Takemura R
    Masui; 1981 Jul; 30(7):741-5. PubMed ID: 7321165
    [No Abstract]   [Full Text] [Related]  

  • 13. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.
    Tremper KK; Friedman AE; Levine EM; Lapin R; Camarillo D
    N Engl J Med; 1982 Jul; 307(5):277-83. PubMed ID: 7045667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Fluosol-DA during open-heart surgery.
    Engelman RM; Dobbs WA; Rousou JH; Anisimowicz L
    Prog Clin Biol Res; 1983; 122():273-82. PubMed ID: 6878370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
    Tremper KK; Anderson ST
    Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the clinical studies of anemia treated with the perfluorochemical emulsion: Fluosol DA 20%.
    Tremper KK
    Prog Clin Biol Res; 1983; 122():307-13. PubMed ID: 6348785
    [No Abstract]   [Full Text] [Related]  

  • 17. New treatment of cerebral vasospasm with Fluosol-DA 20%: protective effect on cerebral ischemia and change of cerebral blood flow (CBF).
    Handa H; Nagasawa S; Yonekawa Y; Naruo Y; Oda Y
    Prog Clin Biol Res; 1983; 122():299-306. PubMed ID: 6878374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluosol-DA as a red-cell substitute in acute anemia.
    N Engl J Med; 1986 Dec; 315(26):1677-8. PubMed ID: 3785341
    [No Abstract]   [Full Text] [Related]  

  • 19. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
    Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
    Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibility of the use of perfluorochemicals (fluorocarbons) as adjuvants in chemotherapy of cancer].
    Kuwamura K; Kokunai T
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1256-61. PubMed ID: 7184453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.